Making Sense of MS Research

Summaries of independent,
high-quality research about multiple sclerosis treatments

Interferons for Relapsing Remitting MS

What is this treatment?

Interferons are considered a ‘first line’ treatment of multiple sclerosis and are commonly prescribed for people with RRMS. In Australia, the Therapeutic Goods Administration (TGA) has approved interferons in the treatment of RRMS. They are also covered under the Pharmaceutical Benefits Scheme (PBS). For more information about how to take interferons you can contact MS Australia and ask to speak with an MS Nurse.